Clinical Trial Update: Xolair Enhances Oral Desensitization in Peanut Allergic Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Xolair (omalizumab) in peanut-allergic patients has completed with posted results, suggesting enhanced oral desensitizatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Lynda Schneider | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-02-20